Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raul Moreno

Showing results (121-130 of 206) with videos related to

Pageof 21
Sort By:
The American Journal of Cardiology|October 24, 2006
Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery diseaseEsther Bernardo, Dominick J Angiolillo, Celia Ramírez, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 16, 2022
Complete versus culprit-only strategy in older MI patients with multivessel diseaseSimone Biscaglia, Andrea Erriquez, Matteo Serenelli, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trialsScot Garg, Giovanna Sarno, Patrick W Serruys, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 15, 2016
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudyDean J Kereiakes, Ian T Meredith, Monica Masotti, et al.
Circulation. Cardiovascular Interventions|June 3, 2026
Impact of Revascularization Completeness on Cardiovascular Outcomes in STEMI With Multivessel DiseaseMehdi Madanchi, Natalia Pinilla-Echeverri, David A Wood, et al.
American Heart Journal|December 17, 2011
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trialGiuseppe Ferrante, Patrizia Presbitero, Elena Corrada, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 20, 2026
GRACE score for risk stratification and completeness of revascularization in older patients with myocardial infarctionLuigi Spadafora, Marco Bernardi, Giuseppe Biondi-Zoccai, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 2, 2021
First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS StudyJose M de la Torre Hernandez, Imanol Otaegui, Asier Subinas, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trialRobbert J de Winter, Azfar Zaman, Hironori Hara, et al.
Thrombosis Research|September 27, 2005
Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery diseaseDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Pageof 21

Showing results (121-130 of 206) with videos related to

Sort By:
Pageof 21
The American Journal of Cardiology|October 24, 2006
Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery diseaseEsther Bernardo, Dominick J Angiolillo, Celia Ramírez, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 16, 2022
Complete versus culprit-only strategy in older MI patients with multivessel diseaseSimone Biscaglia, Andrea Erriquez, Matteo Serenelli, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trialsScot Garg, Giovanna Sarno, Patrick W Serruys, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 15, 2016
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudyDean J Kereiakes, Ian T Meredith, Monica Masotti, et al.
Circulation. Cardiovascular Interventions|June 3, 2026
Impact of Revascularization Completeness on Cardiovascular Outcomes in STEMI With Multivessel DiseaseMehdi Madanchi, Natalia Pinilla-Echeverri, David A Wood, et al.
American Heart Journal|December 17, 2011
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trialGiuseppe Ferrante, Patrizia Presbitero, Elena Corrada, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 20, 2026
GRACE score for risk stratification and completeness of revascularization in older patients with myocardial infarctionLuigi Spadafora, Marco Bernardi, Giuseppe Biondi-Zoccai, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 2, 2021
First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS StudyJose M de la Torre Hernandez, Imanol Otaegui, Asier Subinas, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trialRobbert J de Winter, Azfar Zaman, Hironori Hara, et al.
Thrombosis Research|September 27, 2005
Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery diseaseDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Pageof 21